Penumbra Inc (PEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Penumbra Inc (PEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6595
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Penumbra Inc (Penumbra) is a medical device company that designs, develops, manufactures and markets neuro devices and peripheral devices. The company’s neurovascular mechanical thrombectomy systems include revascularization device, reperfusion catheters, distal delivery catheters, neuro evacuation devices, aspiration pump and accessories, neutron embolization system, and others. Its peripheral thrombectomy systems comprise coil system and delivery micro catheter. Penumbra’s revascularization device is a next generation stroke device designed and optimized for aspiration with ACE reperfusion catheters. The company’s products are used for the treatment of patients with various indications including acute ischemic stroke, brain aneurysm, neuroarteriovenous malformation, acute limb ischemia, deep vein thrombosis, body aneurysm and neurovascular mechanical thrombectomy, among others. It sells its products to hospitals and clinics through its direct sales organization and distributors globally. The company operates its offices in the US, Brazil, Germany and Australia. Penumbra is headquartered in Alameda, California, the US.

Penumbra Inc (PEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Penumbra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Penumbra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Penumbra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Penumbra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Penumbra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Penumbra Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Penumbra Raises US$0.12 Million In Venture Financing 10
Partnerships 11
Penumbra Forms Joint Venture with Sixense Enterprises 11
InspireMD Partners with Penumbra 12
Equity Offering 13
Penumbra Raises USD113.6 Million in Underwritten Public Offering of Shares 13
Penumbra Raises USD138 Million in IPO 15
Penumbra Inc – Key Competitors 17
Penumbra Inc – Key Employees 18
Penumbra Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Financial Announcements 20
Aug 07, 2018: Penumbra announces second quarter 2018 financial results 20
May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results 21
Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results 22
Nov 07, 2017: Penumbra Reports Third Quarter 2017 Financial Results 23
Aug 08, 2017: Penumbra Reports Second Quarter 2017 Financial Results 24
May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 25
Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 26
Corporate Communications 28
Jul 05, 2017: Penumbra Promotes Daniel Davis to Chief Commercial Officer 28
Apr 21, 2017: Penumbra Appoints Bridget O’Rourke to its Board of Directors 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Penumbra Inc, Medical Equipment, Key Facts, 2017 2
Penumbra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Penumbra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Penumbra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Penumbra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Penumbra Inc, Deals By Market, 2012 to YTD 2018 8
Penumbra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Penumbra Raises US$0.12 Million In Venture Financing 10
Penumbra Forms Joint Venture with Sixense Enterprises 11
InspireMD Partners with Penumbra 12
Penumbra Raises USD113.6 Million in Underwritten Public Offering of Shares 13
Penumbra Raises USD138 Million in IPO 15
Penumbra Inc, Key Competitors 17
Penumbra Inc, Key Employees 18
Penumbra Inc, Subsidiaries 19
Penumbra Inc, Joint Venture 19

List of Figures
Penumbra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Penumbra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Penumbra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Penumbra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Penumbra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Penumbra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Penumbra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Penumbra Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Penumbra Inc (PEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hyd …
  • Thomas Cook (India) Limited:企業の戦略・SWOT・財務情報
    Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shiseido Company, Limited:企業の戦略・SWOT・財務情報
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nexeon MedSystems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery …
  • FieldPoint Petroleum Corp (FPP):企業の財務・戦略的SWOT分析
    Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working interests in exploration areas. Its properties comprise South Vacuum field, Block A-49 and Block 6 field, Fly …
  • AngioChem Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AngioChem Inc (AngioChem) is a clinical-stage biotechnology company that discovers and develops new drugs to treat brain related disorders. The company’s products comprise oncology products, peptide antibody conjugates, antibody-drug conjugates, pain products and lysosomal storage diseases p …
  • Senzime AB (SEZI)-医療機器分野:企業M&A・提携分析
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Concho Resources Inc.:企業の戦略・SWOT・財務情報
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SIGA Technologies Inc (SIGA):企業の財務・戦略的SWOT分析
    Summary SIGA Technologies Inc (SIGA) is a health security service provider. The company develops and commercialise solutions for serious unmet medical needs and bio threats. It offers antiviral drug to treat smallpox disease. SIGA offers product such as TPOXX. The company’s Tecovirimat is combined w …
  • GDS Holdings Ltd (GDS):企業の財務・戦略的SWOT分析
    GDS Holdings Ltd (GDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • IPCA Laboratories Ltd (IPCALAB):製薬・医療:M&Aディール及び事業提携情報
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • Dana Brevini Spa
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PSR Group BV-製薬・医療分野:企業M&A・提携分析
    Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company’s PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provi …
  • Exonate Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs, which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The company’s alternative mRNA splicing is modulated in disease states that results in the pathologic …
  • KKR & Co. L.P.:企業の戦略・SWOT・財務情報
    KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Temple Hotels Inc.:企業の戦略・SWOT・財務分析
    Temple Hotels Inc. - Strategy, SWOT and Corporate Finance Report Summary Temple Hotels Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Theranyx Sarl:製薬・医療:M&Aディール及び事業提携情報
    Summary Theranyx Sarl is a bio technology company that develops novel therapeutic drugs and solutions to treat cancer. The company’s main line business involved in generation of functional antibodies to target GPCRs and ion channel receptors. Its antibodies named as Therabodies has scope in target v …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Akers Biosciences Inc (AKER):企業の製品パイプライン分析2018
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆